Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
Clinical trial NCT02707328 · TERMINATED
Trial details
- NCT number
- NCT02707328
- Sponsor
- The Cooper Health System
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-11-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.